These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25676426)

  • 1. An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients.
    Tanemura A; Yang L; Yang F; Nagata Y; Wataya-Kaneda M; Fukai K; Tsuruta D; Ohe R; Yamakawa M; Suzuki T; Katayama I
    J Dermatol Sci; 2015 Mar; 77(3):185-8. PubMed ID: 25676426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of CCR4+ CD8+ T cells and elevated plasma CCL22 and CCL17 in patients with rhododenol-induced leukoderma.
    Nishioka M; Tanemura A; Yang L; Tanaka A; Arase N; Katayama I
    J Dermatol Sci; 2015 Mar; 77(3):188-90. PubMed ID: 25766765
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
    Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T
    J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma.
    Nishigori C; Aoyama Y; Ito A; Suzuki K; Suzuki T; Tanemura A; Ito M; Katayama I; Oiso N; Kagohashi Y; Sugiura S; Fukai K; Funasaka Y; Yamashita T; Matsunaga K
    J Dermatol; 2015 Feb; 42(2):113-28. PubMed ID: 25622988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukoderma induced by rhododendrol is different from leukoderma of vitiligo in pathogenesis: A novel comparative morphological study.
    Tsutsumi R; Sugita K; Abe Y; Hozumi Y; Suzuki T; Yamada N; Yoshida Y; Yamamoto O
    J Cutan Pathol; 2019 Feb; 46(2):123-129. PubMed ID: 30456919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocyte-specific cytotoxic T lymphocytes in patients with rhododendrol-induced leukoderma.
    Fujiyama T; Ikeya S; Ito T; Tatsuno K; Aoshima M; Kasuya A; Sakabe J; Suzuki T; Tokura Y
    J Dermatol Sci; 2015 Mar; 77(3):190-2. PubMed ID: 25724360
    [No Abstract]   [Full Text] [Related]  

  • 7. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.
    Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S
    J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention of pigment stem cells in Rhododenol-induced leukoderma: Pathological investigation of 11 patients.
    Watanabe S; Yagami A; Iwata Y; Nagai A; Kuroda M; Sugiura K; Matsunaga K
    J Dermatol; 2017 Jul; 44(7):e148-e149. PubMed ID: 28516676
    [No Abstract]   [Full Text] [Related]  

  • 9. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin.
    Abe Y; Okamura K; Kawaguchi M; Hozumi Y; Aoki H; Kunisada T; Ito S; Wakamatsu K; Matsunaga K; Suzuki T
    J Dermatol Sci; 2016 Jan; 81(1):35-43. PubMed ID: 26547111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma.
    Yoshikawa M; Sumikawa Y; Hida T; Kamiya T; Kase K; Ishii-Osai Y; Kato J; Kan Y; Kamiya S; Sato Y; Yamashita T
    J Dermatol; 2017 May; 44(5):582-587. PubMed ID: 27882588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique system that can sensitively assess the risk of chemical leukoderma by using murine tail skin.
    Iida M; Tazaki A; Deng Y; Chen W; Yajima I; Kondo-Ida L; Hashimoto K; Ohgami N; Kato M
    Chemosphere; 2019 Nov; 235():713-718. PubMed ID: 31279121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin.
    Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T
    Skin Res Technol; 2018 May; 24(2):175-179. PubMed ID: 29057565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhododendrol-induced leukoderma update I: Clinical findings and treatment.
    Matsunaga K; Suzuki K; Ito A; Tanemura A; Abe Y; Suzuki T; Yoshikawa M; Sumikawa Y; Yagami A; Masui Y; Inoue S; Ito S; Katayama I
    J Dermatol; 2021 Jul; 48(7):961-968. PubMed ID: 33686651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma.
    Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T
    J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhododenol and raspberry ketone impair the normal proliferation of melanocytes through reactive oxygen species-dependent activation of GADD45.
    Kim M; Baek HS; Lee M; Park H; Shin SS; Choi DW; Lim KM
    Toxicol In Vitro; 2016 Apr; 32():339-46. PubMed ID: 26867644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Use of Topical Bimatoprost on Rhododendrol-induced Refractory Leukoderma: A Case Report.
    Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Watanabe S; Tada Y
    Acta Derm Venereol; 2019 Nov; 99(12):1178-1179. PubMed ID: 31449314
    [No Abstract]   [Full Text] [Related]  

  • 17. Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo.
    Inoue S; Katayama I; Suzuki T; Tanemura A; Ito S; Abe Y; Sumikawa Y; Yoshikawa M; Suzuki K; Yagami A; Masui Y; Ito A; Matsunaga K
    J Dermatol; 2021 Jul; 48(7):969-978. PubMed ID: 33951216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebrafish as a new model for rhododendrol-induced leukoderma.
    Hayazaki M; Hatano O; Shimabayashi S; Akiyama T; Takemori H; Hamamoto A
    Pigment Cell Melanoma Res; 2021 Nov; 34(6):1029-1038. PubMed ID: 34310852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanisms of hypopigmentation in lichen sclerosus.
    Carlson JA; Grabowski R; Mu XC; Del Rosario A; Malfetano J; Slominski A
    Am J Dermatopathol; 2002 Apr; 24(2):97-107. PubMed ID: 11979069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(4-hydroroxyphenyl)-2-butanol (rhododendrol) activates the autophagy-lysosome pathway in melanocytes: insights into the mechanisms of rhododendrol-induced leukoderma.
    Yang L; Yang F; Wataya-Kaneda M; Tanemura A; Tsuruta D; Katayama I
    J Dermatol Sci; 2015 Mar; 77(3):182-5. PubMed ID: 25680854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.